Comorbid influences on generic health-related quality of life in COPD: A systematic review

PLoS ONE

Volumn 10, Issue 7, 2015, Pages

  Huber, Manuel B ^a   Wacker, Margarethe E ^a   Vogelmeier, Claus F ^b   Leidl, Reiner ^a,c   Watz, Henrik ^d  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b UNIVERSITY HOSPITAL MARBURG   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

^d Pulmonary Research Institute   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANXIETY DISORDER; ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; DEPRESSION; DIABETES MELLITUS; DISEASE CLASSIFICATION; DISEASE SEVERITY; HEALTH STATUS; HUMAN; MEDICAL RECORD; MUSCULOSKELETAL DISEASE; PHENOTYPE; PREVALENCE; QUALITY OF LIFE; QUESTIONNAIRE; SHORT FORM 12; SHORT FORM 36; SYSTEMATIC REVIEW; COMPLICATION; PATHOPHYSIOLOGY;

HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE;

EID: 84940525008     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0132670     Document Type: Article

References (80)

1. Murray CJL, Lopez AD Measuring the Global Burden of Disease. New England Journal of Medicine. 2013; 369(5):448-57. doi: 10.1056/NEJMra1201534 PMID: 23902484
2. Raherison C, Girodet PO Epidemiology of COPD. Eur Respir Rev. 2009; 18(114):213-21. doi: 10.1183/09059180.00003609 PMID: 20956146
3. Lopez-Otin C., Blasco MA, Partridge L, Serrano M., Kroemer G. The hallmarks of aging. Cell. 2013; 153 (6):1194-217. doi: 10.1016/j.cell.2013.05.039 PMID: 23746838
4. Meiners S, Eickelberg O, Konigshoff M. Hallmarks of the ageing lung. Eur Respir J. 2015. doi:10.1183/ 09031936.00186914
5. Tuder RM, Petrache I. Pathogenesis of chronic obstructive pulmonary disease. J Clin Invest. 2012; 122 (8):2749-55. doi: 10.1172/jci60324 PMID: 22850885
6. Agusti A, Edwards LD, Rennard S.I., MacNee W., Tal-Singer R, Miller BE et al. Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype. PLoS One. 2012; 7(5):e37483. doi: 10.1371/journal.pone.0037483 PMID: 22624038
7. Postma DS, Timens W. Remodeling in Asthma and Chronic Obstructive Pulmonary Disease. Proceedings of the American Thoracic Society. 2006; 3(5):434-9. doi: 10.1513/pats.200601-006AW PMID: 16799088
8. Martinez FJ, Donohue JF, Rennard SI The future of chronic obstructive pulmonary disease treatment - difficulties of and barriers to drug development. Lancet. 2011; 378(9795):1027-37. doi: 10.1016/ s0140-6736(11)61047-7 PMID: 21907866
9. Barnes PJ. New anti-inflammatory targets for chronic obstructive pulmonary disease. Nat Rev Drug Discov. 2013; 12(7):543-59. doi: 10.1038/nrd4025 PMID: 23977698
10. Comer BS, Ba M, Singer C.A., Gerthoffer WT. Epigenetictargets for novel therapies of lung diseases. Pharmacol Ther. 2014. doi:10.1016/j.pharmthera.2014.11.006
11. Fabbri LM, Beghe B, Agusti A. COPD and the solar system: introducing the chronic obstructive pulmonary disease comorbidome. American Journal of Respiratory and Critical Care Medicine. 2012; 186 (2):117-9. doi: 10.1164/rccm.201205-0906ED PMID: 22798411
12. Vanfleteren LEGW, Spruit MA, Groenen M, Gaffron S., van Empel VPM, Bruijnzeel PLB et al. Clusters of Comorbidities Based on Validated Objective Measurements and Systemic Inflammation in Patients with Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 2013; 187(7):728-35. doi: 10.1164/rccm.201209-1665OC PMID: 23392440
13. Gershon AS, Mecredy GC, Guan J, Victor J.C., Goldstein R., To T. Quantifying comorbidity in individuals with COPD: a population study. Eur Respir J. 2015; 45(1):51-9. doi: 10.1183/09031936.00061414 PMID: 25142481
14. Baty F, Putora PM, Isenring B, Blum T., Brutsche M. Comorbidities and Burden of COPD: A Population Based Case-Control Study. PLoS ONE. 2013; 8(5).
15. Divo M, Cote C, de Torres JP, Casanova C, Marin JM, Pinto-Plata V et al. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012; 186 (2):155-61. doi: 10.1164/rccm.201201-0034OC PMID: 22561964
16. Decramer M, Janssens W. Chronic obstructive pulmonary disease and comorbidities. Lancet Respir Med. 2013; 1(1):73-83. doi: 10.1016/s2213-2600(12)70060-7 PMID: 24321806
17. Boyd CM, Vollenweider D, Puhan MA Informing evidence-based decision-making for patients with comorbidity: availability of necessary information in clinical trials for chronic diseases. PLoS One. 2012; 7(8):e41601. doi: 10.1371/journal.pone.0041601 PMID: 22870234
18. Scichilone N, Basile M, Battaglia S., Bellia V. What proportion of chronic obstructive pulmonary disease outpatients is eligible for inclusion in randomized clinical trials? Respiration. 2014; 87(1):11-7. doi: 10.1159/000355082 PMID: 24281343
19. Loscalzo J, Kohane I, Barabasi AL Human disease classification in the postgenomic era: a complex systems approach to human pathobiology. Mol Syst Biol. 2007; 3:124. doi: 10.1038/msb4100163 PMID: 17625512
20. Loscalzo J, Barabasi AL Systems biology and the future of medicine. Wiley Interdiscip Rev Syst Biol Med. 2011; 3(6):619-27. doi: 10.1002/wsbm.144 PMID: 21928407
21. Kind P, Lafata JE, Matuszewski K, Raisch D. The use of QALYs in clinical and patient decision-making: issues and prospects. Value Health. 2009; 12 Suppl 1:S27-30. doi: 10.1111/j.1524-4733.2009.00519. x PMID: 19250128
22. Hillas G, Perlikos F, Tsiligianni I., Tzanakis N. Managing comorbidities in COPD. Int J Chron Obstruct Pulmon Dis. 2015; 10:95-109. doi: 10.2147/copd.s54473 PMID: 25609943
23. Campo G, Pavasini R, Malagu M., Mascetti S, Biscaglia S, Ceconi C et al. Chronic Obstructive Pulmonary Disease and Ischemic Heart Disease Comorbidity: Overview of Mechanisms and Clinical Management. Cardiovasc Drugs Ther. 2015. doi:10.1007/s10557-014-6569-y
24. Fabbri LM, Boyd C, Boschetto P., Rabe KF, Buist AS, Yawn B et al. How to integrate multiple comorbidities in guideline development: article 10 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report. Proc Am Thorac Soc. 2012; 9(5):274-81. doi: 10.1513/ pats.201208-063ST PMID: 23256171
25. Effing TW, Lenferink A, Buckman J., Spicer D, Cafarella PA, BurtMG et al. Development of a self-treatment approach for patients with COPD and comorbidities: an ongoing learning process. J Thorac Dis. 2014; 6(11):1597-605. doi: 10.3978/j.issn.2072-1439.2014.11.14 PMID: 25478200
26. Jones PW, Quirk FH, Baveystock C.M., Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis. 1992; 145 (6):1321-7. doi: 10.1164/ajrccm/145.6.1321 PMID: 1595997
27. EuroQol - a new facility for the measurement of health-related quality of life. Health Policy. 1990; 16 (3):199-208. PMID: 10109801
28. Briggs AH, Glick HA, Lozano-Ortega G, Spencer M, Calverley PM, Jones PW et al. Is treatment with ICS and LABA cost-effective for COPD? Multinational economic analysis of the TORCH study. Eur Respir J. 2010; 35(3):532-9. doi: 10.1183/09031936.00153108 PMID: 19717476
29. Morimoto T, Fukui T. Utilities measured by rating scale, time trade-off, and standard gamble: review and reference for health care professionals. J Epidemiol. 2002; 12(2):160-78. PMID: 12033527
30. Ware JE Jr., Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992; 30(6):473-83. PMID: 1593914
31. Ware J Jr., Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996; 34(3):220-33. PMID: 8628042
32. Sintonen H. The 15D instrument of health-related quality of life: properties and applications. Ann Med. 2001; 33(5):328-36. PMID: 11491191
33. Cleland JA, Lee AJ, Hall S. Associations of depression and anxiety with gender, age, health-related quality of life and symptoms in primary care COPD patients. Fam Pract. 2007; 24(3):217-23. doi: 10.1093/fampra/cmm009 PMID: 17504776
34. Kil SY, Oh WO, Koo B.J., Suk MH. Relationship between depression and health-related quality of life in older Korean patients with chronic obstructive pulmonary disease. J Clin Nurs. 2010; 19(9-10):1307-14. doi: 10.1111/j.1365-2702.2009.03053.x PMID: 20500340
35. Krishnan G, Grant BJ, Muti P.C., Mishra A., Ochs-Balcom HM, Freudenheim JL et al. Association between anemia and quality of life in a population sample of individuals with chronic obstructive pulmonary disease. BMC Pulm Med. 2006; 6:23. doi: 10.1186/1471-2466-6-23 PMID: 16953872
36. Moher D, Liberati A, Tetzlaff J., Altman DG. Preferred reporting items for systematic reviews and metaanalyses: the PRISMA statement. PLoS Med. 2009; 6(7):e1000097. doi: 10.1371/journal.pmed. 1000097 PMID: 19621072
37. Ioannidis JP. Why most published research findings are false. PLoSMed. 2005; 2(8):e124. doi: 10.1371/journal.pmed.0020124 PMID: 16060722
38. Boros PW, Lubinski W. Health state and the quality of life in patients with chronic obstructive pulmonary disease in Poland: A study using the EQ-5D questionnaire. PolskieArchiwumMedycyny Wewnetrznej. 2012; 122(3):73-81. PMID: 22354456
39. Frei A, Muggensturm P, Putcha N., Siebeling L, Zoller M, Boyd CM et al. Five comorbidities reflected the health status in patients with chronic obstructive pulmonary disease: the newly developed COMCOLD index. J Clin Epidemiol. 2014; 67(8):904-11. doi: 10.1016/j.jclinepi.2014.03.005 PMID: 24786594
40. Naberan K, Azpeitia A, Cantoni J., Miravitlles M. Impairment of quality of life in women with chronic obstructive pulmonary disease. Respir Med. 2012; 106(3):367-73. doi: 10.1016/j.rmed.2011.09.014 PMID: 22018505
41. Rutten-van Molken MP, Oostenbrink JB, Tashkin DP, Burkhart D, Monz BU. Does quality of life of COPD patients as measured by the generic EuroQol five-dimension questionnaire differentiate between COPD severity stages? Chest. 2006; 130(4):1117-28. doi: 10.1378/chest.130.4.1117 PMID: 17035446
42. Sundh J, Johansson G, Larsson K., Linden A, Lofdahl CG, Janson C et al. Comorbidity and health-related quality of life in patients with severe chronic obstructive pulmonary disease attending Swedish secondary care units. Int J Chron Obstruct Pulmon Dis. 2015; 10:173-83. doi: 10.2147/copd.s74645 PMID: 25653516
43. Miravitlles M, Molina J, Quintano J.A., Campuzano A., Perez J, Roncero C. Factors associated with depression and severe depression in patients with COPD. Respir Med. 2014; 108(11):1615-25. doi: 10.1016/j.rmed.2014.08.010 PMID: 25312692
44. Wacker ME, Hunger M, Karrasch S., Heinrich J, Peters A, Schulz H et al. Health-related quality of life and chronic obstructive pulmonary disease in early stages - longitudinal results from the population-based KORA cohort in a working age population. BMC Pulmonary Medicine. 2014; 14(1).
45. Janson C, Marks G, Buist S., Gnatiuc L, Gislason T, McBurnie MA et al. The impact of COPD on health status: findings from the BOLD study. Eur Respir J. 2013; 42(6):1472-83. doi: 10.1183/09031936. 00153712 PMID: 23722617
46. Lopez Varela M.V., Montes de Oca M, Halbert R, Muino A, Talamo C, Perez-Padilla R et al. Comorbidities and health status in individuals with and without COPD in five Latin American cities: the PLATINO study. Arch Bronconeumol. 2013; 49(11):468-74. doi: 10.1016/j.arbres.2013.05.003 PMID: 23856439
47. de Miguel-Diez J, Carrasco-Garrido P, Rejas-Gutierrez J, Martin-Centeno A, Gobartt-Vazquez E, Hernandez-Barrera V et al. The influence of heart disease on characteristics, quality of life, use of health resources, and costs of COPD in primary care settings. BMC Cardiovascular Disorders. 2010; 10(8).
48. Ng TP, Niti M, Fones C., Yap KB, Tan WC. Co-morbid association of depression and COPD: a population-based study. Respir Med. 2009; 103(6):895-901. doi: 10.1016/j.rmed.2008.12.010 PMID: 19136238
49. Xiang YT, Wong TS, Tsoh J, Ungvari G.S., Correll CU, Sareen J et al. Quality of Life in Older Patients With Chronic Obstructive Pulmonary Disease (COPD) in Hong Kong: A Case-Control Study. Perspect Psychiatr Care. 2014. doi:10.1111/ppc.12073
50. van Manen J.G., Bindels PJ, Dekker F.W., Bottema BJ, van der Zee JS, Ijzermans CJ et al. The influence of COPD on health-related quality of life independent of the influence of comorbidity. J Clin Epidemiol. 2003; 56(12):1177-84. PMID: 14680668
51. Rascon-Aguilar I.E., Pamer M, Wludyka P., Cury J, Vega KJ. Poorly treated or unrecognized GERD reduces quality of life in patients with COPD. Dig Dis Sci. 2011; 56(7):1976-80. doi: 10.1007/s10620-010-1542-5 PMID: 21221789
52. Cully JA, Graham DP, Stanley M.A., Ferguson CJ, Sharafkhaneh A, Souchek J et al. Quality of life in patients with chronic obstructive pulmonary disease and comorbid anxiety or depression. Psychosomatics. 2006; 47(4):312-9. PMID: 16844889
53. van Manen J.G., Bindels PJ, Dekker E.W., Ijzermans CJ, Bottema BJ, van der Zee JS et al. Added value of co-morbidity in predicting health-related quality of life in COPD patients. Respir Med. 2001; 95 (6):496-504. PMID: 11421508
54. Koskela J, Kilpelainen M, Kupiainen H., Mazur W, Sintonen H, Boezen M et al. Co-morbidities are the key nominators of the health related quality of life in mild and moderate COPD. BMC Pulm Med. 2014; 14:102. doi: 10.1186/1471-2466-14-102 PMID: 24946786
55. Blinderman CD, Homel P, Andrew Billings J, Tennstedt S, Portenoy RK Symptom Distress and Quality of Life in Patients with Advanced Chronic Obstructive Pulmonary Disease. Journal of Pain and Symptom Management. 2009; 38(1):115-23. doi: 10.1016/j.jpainsymman.2008.07.006 PMID: 19232893
56. Putcha N, Puhan MA, Hansel N.N., Drummond MB, Boyd CM. Impact of co-morbidities on self-rated health in self-reported COPD: an analysis of NHANES 2001-2008. Copd. 2013; 10(3):324-32. doi: 10.3109/15412555.2012.744963 PMID: 23713595
57. Bentsen SB, Miaskowski C, Rustoen T. Demographic and clinical characteristics associated with quality of life in patients with chronic obstructive pulmonary disease. Quality of life research: an international journal of quality of life aspects of treatment, care and rehabilitation. 2014; 23(3):991-8.
58. Shavro SA, Ezhilarasu P, Augustine J., Bechtel JJ, Christopher DJ. Correlation of health-related quality of life with other disease severity indices in Indian chronic obstructive pulmonary disease patients. International journal of chronic obstructive pulmonary disease. 2012; 7:291-6. doi: 10.2147/COPD. S26405 PMID: 22615528
59. Wijnhoven HA, Kriegsman DM, Hesselink A.E., de Haan M, Schellevis FG. The influence of co-morbidity on health-related quality of life in asthma and COPD patients. RespirMed. 2003; 97(5):468-75. PMID: 12735662
60. Dolan P. Modeling valuations for EuroQol health states. Med Care. 1997; 35(11):1095-108. PMID: 9366889
61. Shaw JW, Johnson JA, Coons SJ US valuation of the EQ-5D health states: development and testing of the D1 valuation model. Med Care. 2005; 43(3):203-20. PMID: 15725977
62. Badia X, Roset M, Montserrat S., Herdman M, Segura A. [The Spanish version of EuroQol: a description and its applications. European Quality of Life scale]. Med Clin (Barc). 1999; 112 Suppl 1:79-85.
63. Avis NE, Smith KW, Hambleton R.K., Feldman HA, Selwyn A, Jacobs A. Development of the multidimensional index of life quality. A quality of life measure for cardiovascular disease. Med Care. 1996; 34 (11):1102-20. PMID: 8911427
64. Burckhardt CS, Woods SL, Schultz A.A., Ziebarth DM. Quality of life of adults with chronic illness: a psychometric study. Res Nurs Health. 1989; 12(6):347-54. PMID: 2602575
65. Skevington SM, Lotfy M, O'Connell KA. The World Health Organization's WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHOQOLgroup. Qual Life Res. 2004; 13(2):299-310. PMID: 15085902
66. Centers for Disease Control and Prevention Measuring Healthy Days: Population assessment of health-related quality of life. CDC, Atlanta Georgia. 2000. http://www.cdc.gov/hrqol/hrqo114measure.htm.
67. Hunt SM, McKenna SP, McEwen J, Backett E.M., Williams J., Papp E. A quantitative approach to perceived health status: a validation study. J Epidemiol Community Health. 1980; 34(4):281-6. PMID: 7241028
68. Mullerova H, Agusti A, Erqou S., Mapel DW. Cardiovascular comorbidity in COPD: systematic literature review. Chest. 2013; 144(4):1163-78. doi: 10.1378/chest.12-2847 PMID: 23722528
69. Miyazaki M, Nakamura H, Chubachi S., Sasaki M, Haraguchi M, Yoshida S et al. Analysis of comorbid factors that increase the COPD assessment test scores. Respir Res. 2014; 15:13. doi: 10.1186/1465-9921-15-13 PMID: 24502760
70. Gläser S., Krüger S, Merkel M., Bramlage P, Herth FJF. Chronic Obstructive Pulmonary Disease and Diabetes Mellitus: A Systematic Review of the Literature. Respiration. 2015; 89(3):253-64. doi: 10.1159/000369863 PMID: 25677307
71. Parappil A, Depczynski B, Collett P., Marks GB. Effect of comorbid diabetes on length of stay and risk of death in patients admitted with acute exacerbations of COPD. Respirology. 2010; 15(6):918-22. doi: 10.1111/j.1440-1843.2010.01781.x PMID: 20546185
72. Marquis K, Debigare R, Lacasse Y., Le Blanc P, Jobin J, Carrier G et al. Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2002; 166(6):809-13. doi: 10.1164/rccm.2107031 PMID: 12231489
73. Swallow EB, Reyes D, Hopkinson N.S., Man WD, Porcher R, Cetti EJ et al. Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease. Thorax. 2007; 62 (2):115-20. doi: 10.1136/thx.2006.062026 PMID: 17090575
74. Cohen S, Nathan JA, Goldberg AL Muscle wasting in disease: molecular mechanisms and promising therapies. Nat Rev Drug Discov. 2015; 14(1):58-74. doi: 10.1038/nrd4467 PMID: 25549588
75. Engstrom CP, Persson LO, Larsson S, Sullivan M. Health-related quality of life in COPD: why both disease-specific and generic measures should be used. Eur Respir J. 2001; 18(1):69-76. PMID: 11510808
76. Huber MB, Wacker ME, Vogelmeier C.F., Leidl R. Excess Costs of Comorbidities in Chronic Obstructive Pulmonary Disease: A Systematic Review. PLoSOne. 2015; 10(4):e0123292. doi: 10.1371/journal. pone.0123292 PMID: 25875204
77. Leidl R, Reitmeir P. A value set for the EQ-5D based on experienced health states: development and testing for the German population. Pharmacoeconomics. 2011; 29(6):521-34. doi: 10.2165/11538380-000000000-00000 PMID: 21247225
78. Ara R, Brazier J. Comparing EQ-5D scores forcomorbid health conditions estimated using 5 different methods. Med Care. 2012; 50(5):452-9. doi: 10.1097/MLR.0b013e318234a04a PMID: 22002647
79. Hanmer J, Vanness D, Gangnon R., Palta M, Fryback DG. Three methods tested to model SF-6D health utilities for health states involving comorbidity/co-occurring conditions. J Clin Epidemiol. 2010; 63 (3):331-41. doi: 10.1016/j.jclinepi.2009.06.013 PMID: 19896802
80. Ara R, Wailoo AJ Estimating health state utility values for joint health conditions: a conceptual review and critique of the current evidence. Med Decis Making. 2013; 33(2):139-53. doi: 10.1177/0272989x12455461 PMID: 22927696